CLINICAL_TRIALS ClinicalTrials.gov record update

Open-Label Single-Arm Pilot Study of Deferasirox (Exjade®) in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00602446
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:42.954348+00:00
Published At: 2010-03-30T00:00:00+00:00
Record Updated At: 2017-12-28
Results Posted At: 2010-03-30
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Breast Cancer", "Iron Overload", "Leukemia", "Lymphoma", "Multiple Myeloma and Plasma Cell Neoplasm", "Myelodysplastic Syndromes", "Neuroblastoma", "Ovarian Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2017-12-28"
protocolSection.identificationModule.nctId: "NCT00602446"
protocolSection.identificationModule.officialTitle: "Open-Label Single-Arm Pilot Study of Deferasirox (Exjade\u00ae) in Adult Allogeneic Hematopoietic Stem Cell Transplant Recipients With Transfusional Iron Overload"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2010-03-30"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.